|

Impact of Del Nido Versus Blood Cardioplegia on Myocardial Viability Assessed With Magnetic Resonance Imaging

RECRUITINGN/ASponsored by Klinički Bolnički Centar Zagreb
Actively Recruiting
PhaseN/A
SponsorKlinički Bolnički Centar Zagreb
Started2026-06-01
Est. completion2027-06-01
Eligibility
Age18 Years – 80 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07637266

Summary

Myocardial protection during surgical myocardial revascularization is crucial for reducing perioperative myocardial injury and improving postoperative outcomes. Blood cardioplegia represents the standard method in many centers, while del Nido cardioplegia, originally developed for the pediatric population, is increasingly being used in adult patients as well.

Eligibility

Age: 18 Years – 80 YearsHealthy volunteers accepted
Eligibility Criteria:

1\. Patients with multivessel coronary artery disease scheduled for elective coronary artery bypass grafting

Exclusion Criteria:

1. Left ventricular ejection fraction \<30%
2. Associated cardiac procedures
3. Off-pump coronary artery bypass grafting
4. Contraindications for MRI
5. Inability to provide consent

Conditions3

CABGHeart DiseaseMyocardial Viability

Interventions2

Blood Cardioplegia Solution for myocardial protectionDel Nido Cardioplegia Solution for myocardial protection

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.